Set to open in 2024, the $206 million ACMD facility will foster collaboration and enhance Victoria’s bioengineering research capabilities.
Machine learning has in recent years been gaining prominence across a number of domains, and this technology also has strong potential for application in bioinformatics and healthcare. A sub-field of artificial intelligence, machine learning involves ‘teaching’ a computer program to learn from its experience of data, resulting in better recognition of patterns over time.
New SVI research on lipoedema – a debilitating chronic disease often misdiagnosed as obesity – provides a path to potential drug treatments and development of a diagnostic screening test.
Type 1 diabetes is just one of many diseases that turn Australian lives upside down every day. Scientists at SVI are applying ‘big data’ analysis and artificial intelligence to drive quantum leaps in our knowledge of disease, including type 1 diabetes.
SVI is excited to have secured a $2.5 million grant through The Ian Potter Foundation to support the Aikenhead Centre for Medical Discovery (ACMD). SVI is one of nine partners in the ACMD, a new centre that will accelerate bio-engineering medical solutions for people living with disease, and position Australia as a leader within a rapidly evolving global industry.
Around 250 Australians are diagnosed with dementia every day, with the majority of these people affected by Alzheimer’s disease.
Congratulations to Dr Jacki Heraud-Farlow and Dr Kim Loh, who were both awarded Ideas Grants in the Australian Government’s National Health and Medical Research Council 2022 funding round.
SVI wishes to announce that the Auditors appointed to Audit the Financial Statutory Accounts for SVI have been changed, effective December 2022.